dbACP: A Comprehensive Database of Anti-Cancer Peptides

6 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp07194 DEK GLLDLLELLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 1.14 ± 0.52 µM
dbacp07195 DEK GLLDLLELLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 0.70 ± 0.07 µM
dbacp07196 DEK GLLDLLELLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 19.88 ± 2.65 µM
dbacp07233 d-DEK GlldllelllkaaGw Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 0.44 ± 0.10 µM
dbacp07234 d-DEK GlldllelllkaaGw Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 0.36 ± 0 µM
dbacp07235 d-DEK GlldllelllkaaGw Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 5.84 ± 0.04 µM